Sangamo Therapeutics (SGMOQ) Return on Sales (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted quarterly Return on Sales of 0.03% for Q4 2025, up 1.0% year-over-year from 0.03% in Q4 2024, and up 95.63% quarter-over-quarter from 0.6% in Q3 2025.
Sangamo Therapeutics (SGMOQ) Return on Sales (2010 - 2025) Analysis & Trends
Sangamo Therapeutics' Return on Sales history runs 16 years deep, the most recent figure standing at 0.03% for Q4 2025.
- In Q4 2025, Return on Sales rose 1.0% year-over-year to 0.03%; the TTM figure through Dec 2025 stood at 0.03% (down 1.0% YoY), while the FY2025 annual figure was 0.03%, down 1.0% from the prior year.
- Return on Sales for Q4 2025 stood at 0.03%, up from 0.6% in the prior quarter.
- The five-year high for Return on Sales was 0.0% in Q3 2024, with the low at 1.02% in Q1 2024.
- The 5-year median for Return on Sales is 0.02% (2022), against an average of 0.17%.
- The sharpest annual moves came in 2024 and 2025: Return on Sales sank 102 bps in 2024, then jumped 100 bps in 2025.
- Sangamo Therapeutics' Return on Sales stood at 0.01% in 2021, then plunged by 42 bps to 0.02% in 2022, then tumbled by 1448 bps to 0.3% in 2023, then soared by 88 bps to 0.04% in 2024, then rose by 27 bps to 0.03% in 2025.
- Business Quant data shows SGMOQ's Return on Sales at 0.03% in Q4 2025, 0.6% in Q3 2025, and 0.01% in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.60% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.05% |
| Dec 31, 2024 | -0.04% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -1.01% |
| Mar 31, 2024 | -1.02% |
| Dec 31, 2023 | -0.30% |
| Sep 30, 2023 | -0.11% |
| Jun 30, 2023 | -0.17% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.02% |
| Jun 30, 2021 | -0.02% |
| Mar 31, 2021 | -0.02% |